Difficulty: Medium
Average Score: 89%
Practice
The use of morphine in the patient who has had a myocardial infarction (MI) centers around three distinct pharmacologic properties. Which of the following choices includes these properties?
Correct answer
C
Rationale
The correct answer is C) Relief of anxiety, preload reduction, and relief of pain.
1. Relief of anxiety: Morphine, a potent opioid analgesic, has sedative properties that help alleviate anxiety in patients, especially those who have experienced a myocardial infarction (MI). By reducing anxiety, morphine can help lower sympathetic activity and reduce myocardial oxygen demand.
2. Preload reduction: Morphine can cause venous vasodilation, leading to decreased preload. This effect reduces the amount of blood returning to the heart, which in turn can decrease myocardial oxygen demand and workload, benefiting a patient who has had an MI.
3. Relief of pain: Morphine is a powerful pain reliever that acts centrally to modulate pain perception. In the context of a patient who has had an MI, controlling pain is crucial not only for comfort but also because uncontrolled pain can increase sympathetic tone and cardiac workload.
Why other options are wrong:
A) Relief of pain, relief of anxiety, and increased oxygen supply: While relief of pain and anxiety are relevant effects of morphine, there is no direct mechanism by which morphine increases oxygen supply in the context of a myocardial infarction.
B) Relief of anxiety, afterload reduction, increased preload: While morphine can reduce preload, it does not typically affect afterload. Increased preload is not desirable in the setting of an MI.
D) Vagomimetic effect, relief of anxiety, respiratory depression: While morphine can cause respiratory depression, the terms "vagomimetic effect" and "respiratory depression" are not primary pharmacologic properties of morphine in the context of its use post-MI.
Educational context:
Understanding the pharmacological properties of CNS drugs like morphine is crucial for healthcare professionals managing patients with various conditions, including myocardial infarction. By grasping how these medications work, healthcare providers can make informed decisions about drug therapy to optimize patient outcomes and safety.
1. Relief of anxiety: Morphine, a potent opioid analgesic, has sedative properties that help alleviate anxiety in patients, especially those who have experienced a myocardial infarction (MI). By reducing anxiety, morphine can help lower sympathetic activity and reduce myocardial oxygen demand.
2. Preload reduction: Morphine can cause venous vasodilation, leading to decreased preload. This effect reduces the amount of blood returning to the heart, which in turn can decrease myocardial oxygen demand and workload, benefiting a patient who has had an MI.
3. Relief of pain: Morphine is a powerful pain reliever that acts centrally to modulate pain perception. In the context of a patient who has had an MI, controlling pain is crucial not only for comfort but also because uncontrolled pain can increase sympathetic tone and cardiac workload.
Why other options are wrong:
A) Relief of pain, relief of anxiety, and increased oxygen supply: While relief of pain and anxiety are relevant effects of morphine, there is no direct mechanism by which morphine increases oxygen supply in the context of a myocardial infarction.
B) Relief of anxiety, afterload reduction, increased preload: While morphine can reduce preload, it does not typically affect afterload. Increased preload is not desirable in the setting of an MI.
D) Vagomimetic effect, relief of anxiety, respiratory depression: While morphine can cause respiratory depression, the terms "vagomimetic effect" and "respiratory depression" are not primary pharmacologic properties of morphine in the context of its use post-MI.
Educational context:
Understanding the pharmacological properties of CNS drugs like morphine is crucial for healthcare professionals managing patients with various conditions, including myocardial infarction. By grasping how these medications work, healthcare providers can make informed decisions about drug therapy to optimize patient outcomes and safety.